Retatrutide – Triple Agonist Research Peptide

Retatrutide is a novel GLP-1, GIP, and glucagon receptor agonist under investigation for its role in fat loss, metabolic control, and appetite suppression.

Mechanisms:

• GLP-1: appetite reduction, insulin enhancement
• GIP: insulin co-activation
• Glucagon: fat breakdown and energy boost

Strengths: 10mg, 20mg, 30mg, 50mg

Fully labelled with expiry and lot code. For research use only.